Directed share issue in Integrum AB — SEK 121 million Healthcare Directed share issue in Integrum AB — SEK 121 million
Directed share issue in Q-linea AB — SEK 301 million Healthcare Directed share issue in Q-linea AB — SEK 301 million
Private placement in Måsøval (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 825 million Agriculture & Aquaculture Private placement in Måsøval (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 825 million
Private placement of new shares in Calanus AS (NO) and an undisclosed secondary sale to Broodstock Capital – NOK 100 million Agriculture & Aquaculture Private placement of new shares in Calanus AS (NO) and an undisclosed secondary sale to Broodstock Capital – NOK 100 million
Rights and directed issues in Heimstaden AB (SE) — SEK 1,125 million Real Estate Rights and directed issues in Heimstaden AB (SE) — SEK 1,125 million
Directed share issue in Integrum AB — SEK 121 million Healthcare Directed share issue in Integrum AB — SEK 121 million
Directed share issue in IRRAS AB — SEK 66 million Healthcare Directed share issue in IRRAS AB — SEK 66 million
Rights issue and Over-Allotment Option in Isofol Medical AB (SE) — SEK 500 million Healthcare Rights issue and Over-Allotment Option in Isofol Medical AB (SE) — SEK 500 million
Directed share issue in SalMar ASA (NO) — NOK 2,709 million Agriculture & Aquaculture Directed share issue in SalMar ASA (NO) — NOK 2,709 million
Directed share issue in Cloudberry Clean Energy ASA — NOK 1,075 million Cleantech, Renewables & Infrastructure Directed share issue in Cloudberry Clean Energy ASA — NOK 1,075 million
Directed share issue in Swedish Stirling AB — SEK 225 million Cleantech, Renewables & Infrastructure Directed share issue in Swedish Stirling AB — SEK 225 million
Placing of shares in Nordnet AB (SE) — SEK 3,360 million FIG Placing of shares in Nordnet AB (SE) — SEK 3,360 million